AstraZeneca VP to discuss COVID-19 collaboration with VUMC Nov. 17
Mark Esser, PhD by Bill Snyder On Thursday, Nov. 17, Mark Esser, PhD, vice president, Early Vaccines and Immune Therapies R&D at AstraZeneca, will discuss his company’s collaboration with Vanderbilt University Medical Center that led…